Sara E Oliver1, Pamina M Gorbach2, Beau Gratzer3, Martin Steinau4, Tom Collins5, Adam Parrish5, Peter R Kerndt4, Richard A Crosby5, Elizabeth R Unger6, Lauri E Markowitz1, Elissa Meites1. 1. From the Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA. 2. Fielding School of Public Health, University of California at Los Angeles, Los Angeles, CA. 3. Howard Brown Health, Chicago, IL. 4. Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA. 5. College of Public Health, University of Kentucky, Lexington, KY. 6. Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA.
Abstract
BACKGROUND: Men who have sex with men (MSM) are at risk for cancers attributable to human papillomavirus (HPV), including oropharyngeal cancer. Human papillomavirus vaccination is recommended for US MSM through age 26 years. Oral HPV infection is associated with oropharyngeal cancer. We determined oral HPV prevalence and risk factors among young MSM. METHODS: The Young Men's HPV study enrolled MSM aged 18 through 26 years from clinics in Chicago and Los Angeles during 2012 to 2014. Participants self-reported demographics, sexual behaviors, vaccination and human immunodeficiency virus (HIV) status. Self-collected oral rinse specimens were tested for HPV DNA (37 types) by L1-consensus PCR. We calculated adjusted prevalence ratios (aPR) and 95% confidence intervals (CI) for risk factors associated with oral HPV among participants not previously vaccinated. RESULTS: Oral HPV was detected in 87 (9.4%) of 922; 9-valent vaccine types were detected in 37 (4.0%) of 922. Among HIV-positive participants, 17 (19.3%) of 88 had oral HPV detected. Oral HPV was more prevalent among those reporting first sex at 18 years of age or younger (aPR, 2.44; 95% CI, 1.16-5.12); HIV infection (aPR, 1.99; 95% CI, 1.14-3.48); greater than 5 sex partners within the past month (aPR, 1.93; 95% CI, 1.13-3.31); performing oral sex on greater than 5 partners within the last 3 months (aPR, 1.87; 95% CI, 1.12-3.13); and having greater than 5 male sex partners within the last 3 months (aPR, 1.76; 95% CI, 1.08-2.87). Only 454 (49.2%) of 922 were aware that HPV can cause oropharyngeal cancers. CONCLUSIONS: Many oral HPV infections were with types targeted by vaccination. Oral HPV infections were significantly associated with HIV and sexual behaviors. Fewer than half of participants were aware that HPV could cause oropharyngeal cancer.
BACKGROUND:Men who have sex with men (MSM) are at risk for cancers attributable to human papillomavirus (HPV), including oropharyngeal cancer. Humanpapillomavirus vaccination is recommended for US MSM through age 26 years. Oral HPV infection is associated with oropharyngeal cancer. We determined oral HPV prevalence and risk factors among young MSM. METHODS: The Young Men's HPV study enrolled MSM aged 18 through 26 years from clinics in Chicago and Los Angeles during 2012 to 2014. Participants self-reported demographics, sexual behaviors, vaccination and human immunodeficiency virus (HIV) status. Self-collected oral rinse specimens were tested for HPV DNA (37 types) by L1-consensus PCR. We calculated adjusted prevalence ratios (aPR) and 95% confidence intervals (CI) for risk factors associated with oral HPV among participants not previously vaccinated. RESULTS:Oral HPV was detected in 87 (9.4%) of 922; 9-valent vaccine types were detected in 37 (4.0%) of 922. Among HIV-positive participants, 17 (19.3%) of 88 had oral HPV detected. Oral HPV was more prevalent among those reporting first sex at 18 years of age or younger (aPR, 2.44; 95% CI, 1.16-5.12); HIV infection (aPR, 1.99; 95% CI, 1.14-3.48); greater than 5 sex partners within the past month (aPR, 1.93; 95% CI, 1.13-3.31); performing oral sex on greater than 5 partners within the last 3 months (aPR, 1.87; 95% CI, 1.12-3.13); and having greater than 5 male sex partners within the last 3 months (aPR, 1.76; 95% CI, 1.08-2.87). Only 454 (49.2%) of 922 were aware that HPV can cause oropharyngeal cancers. CONCLUSIONS: Many oral HPV infections were with types targeted by vaccination. Oral HPV infections were significantly associated with HIV and sexual behaviors. Fewer than half of participants were aware that HPV could cause oropharyngeal cancer.
Authors: Aaron A R Tobian; Godfrey Kigozi; Patti E Gravitt; Changchang Xiao; David Serwadda; Kevin P Eaton; Xiangrong Kong; Maria J Wawer; Fred Nalugoda; Thomas C Quinn; Ronald H Gray Journal: AIDS Date: 2012-07-31 Impact factor: 4.177
Authors: Dorothy A Machalek; Mary Poynten; Fengyi Jin; Christopher K Fairley; Annabelle Farnsworth; Suzanne M Garland; Richard J Hillman; Kathy Petoumenos; Jennifer Roberts; Sepehr N Tabrizi; David J Templeton; Andrew E Grulich Journal: Lancet Oncol Date: 2012-03-23 Impact factor: 41.316
Authors: Anil K Chaturvedi; Eric A Engels; Ruth M Pfeiffer; Brenda Y Hernandez; Weihong Xiao; Esther Kim; Bo Jiang; Marc T Goodman; Maria Sibug-Saber; Wendy Cozen; Lihua Liu; Charles F Lynch; Nicolas Wentzensen; Richard C Jordan; Sean Altekruse; William F Anderson; Philip S Rosenberg; Maura L Gillison Journal: J Clin Oncol Date: 2011-10-03 Impact factor: 44.544
Authors: Zoe R Edelstein; Stephen M Schwartz; Stephen Hawes; James P Hughes; Qinghua Feng; Michael E Stern; Sandra O'Reilly; Shu-Kuang Lee; Long Fu Xi; Laura A Koutsky Journal: Sex Transm Dis Date: 2012-11 Impact factor: 2.830
Authors: Gypsyamber D'Souza; Aimee R Kreimer; Raphael Viscidi; Michael Pawlita; Carole Fakhry; Wayne M Koch; William H Westra; Maura L Gillison Journal: N Engl J Med Date: 2007-05-10 Impact factor: 91.245
Authors: Suzanne M Garland; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonzalo Perez; Diane M Harper; Sepp Leodolter; Grace W K Tang; Daron G Ferris; Marc Steben; Janine Bryan; Frank J Taddeo; Radha Railkar; Mark T Esser; Heather L Sings; Micki Nelson; John Boslego; Carlos Sattler; Eliav Barr; Laura A Koutsky Journal: N Engl J Med Date: 2007-05-10 Impact factor: 91.245
Authors: Elissa Meites; Pamina M Gorbach; Beau Gratzer; Gitika Panicker; Martin Steinau; Tom Collins; Adam Parrish; Cody Randel; Mark McGrath; Steven Carrasco; Janell Moore; Akbar Zaidi; Jim Braxton; Peter R Kerndt; Elizabeth R Unger; Richard A Crosby; Lauri E Markowitz Journal: J Infect Dis Date: 2016-06-13 Impact factor: 5.226
Authors: Eleonore B Baughan; Erin M Keizur; Christopher A Damico; Elizabeth Mayfield Arnold; Jamie S Ko; Jeffrey D Klausner Journal: Sex Transm Dis Date: 2019-08 Impact factor: 2.830
Authors: Sarah J Robbins; Wuese Dauda; Afoke Kokogho; Nicaise Ndembi; Andrew Mitchell; Sylvia Adebajo; Charlotte A Gaydos; Sheila Peel; Habib O Ramadhani; Merlin L Robb; Stefan D Baral; Julie A Ake; Man E Charurat; Trevor A Crowell; Rebecca G Nowak Journal: PLoS One Date: 2020-09-04 Impact factor: 3.240
Authors: Ryan D Assaf; Marjan Javanbakht; Elissa Meites; Beau Gratzer; Martin Steinau; Richard A Crosby; Lauri E Markowitz; Elizabeth R Unger; Pamina M Gorbach Journal: Sex Transm Dis Date: 2020-07 Impact factor: 3.868